HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

5th Edition of Cardiology World Conference

September 5-7, 2024 | Madrid, Spain

September 05 -07, 2024 | Madrid, Spain

Cardio 2024

Naranjan S Dhalla, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Naranjan S Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada

Although different antiplatelet agents are used for the prevention of thrombosis and treatment of ischemic heart disease, very little information regarding therapeutic potential of these agents in heart failure is available. We have investigated the effects of some antiplatelet a [....] » Read More

Yong Xiao Wang, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical Center, United States

Pulmonary hypertension (PH) is a common and devastating lung disease. The current primary interventions for this disease are to use non-specific vasodilators, but patients do not always respond well to these non-specific vasodilators. Voltage-dependent potassium channels and stor [....] » Read More

Kumar Ponniah, Speaker at Cardiology Conference
Keynote Presentation (In-Person)
Kumar Ponniah, Wolfson Terry Heart Institute, United States

Coronary artery abnormalities whether congenital or acquired are an important cause of morbidity and mortality in Children. The current talk will focus on Congenital coronary abnormalities as well acquired coronary disease i.e., Kawasaki disease in children. Coronary Artery An [....] » Read More

David Tamrazyan, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
David Tamrazyan, Krasnodar State University, Spain

Cardiometry is a new basic science that will make the diagnosis of cardiovascular pathology easier, cheaper and faster. New perspectives in the study of the hemodynamics of the organism. Cardiometry gives us the opportunity to see the functioning of our body from a different pers [....] » Read More

Jose Maria Castellano Vazquez, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Jose Maria Castellano Vazquez, National Center for Cardiovascular Research (CNIC), Spain

Background: The incidence of recurrent cardiovascular (CV) events (CVe) and all-cause mortality is high among patients in secondary prevention. The SECURE trial demonstrated that the CNIC-Polypill Strategy combining acetylsalicylic acid [ASA], atorvastatin and ramipril into a sin [....] » Read More

Gurkamal Sohal, Speaker at Heart Conferences
Oral Presentation (In-Person)
Gurkamal Sohal, University Hospitals Birmingham NHS Foundation Trust, United Kingdom

This 16-year-old male presented by recurrent dizziness, escalating to blank spells resulting in sudden, non-exertion-related syncope. Despite extensive medical evaluations including normal clinical examination, blood pressure readings (lying and standing), EEG, resting ECG, echoc [....] » Read More

Chaoneng Wu, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Chaoneng Wu, Michigan State University, United States

Introduction: Insulin resistance (IR) means defective insulin stimulated glucose uptake accompanied by impaired insulin induced suppression of hepatic glucose output. Hypertriglyceridemia (HTG) constitutes a critical component of metabolic syndrome, which includes obesity, H [....] » Read More

Chinh Duc Nguyen, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Chinh Duc Nguyen, Can Tho Stroke International Services, Vietnam

Introduction: Coronary artery disease is the leading cause of death among non-communicable diseases. Management stragedy emphasizes on early detection and optimal treatment, with emerging roles of imaging approaches. Photon-couting computed tomography is a new non-invasive diagno [....] » Read More

Veronika Kachmar, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Veronika Kachmar, Jagiellonian University Medical College, Poland

Atrial fibrillation (AF) is the most common significant cardiac rhythm disorder and is also a powerful common risk factor for stroke: about 15% of all strokes in the U.S. are attributable to AF. The use of combined antiplatelet and anticoagulant therapy in patients with AF has re [....] » Read More

Chaoneng Wu, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Chaoneng Wu, Michigan State University, United States

Introduction: Diabetic autonomic neuropathy (DAN) impacts cardiovascular health with an increasing prevalence over diabetic course, affecting up to 50% of patients after 15 years. Notably, DAN-associated cardiovascular autonomic neuropathy (CAN) have a mortality rate of 16% to 50 [....] » Read More

Kelly Ka Yee Chu, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Kelly Ka Yee Chu, East & North Hertfordshire NHS Trust, United Kingdom

Objectives: To investigate how virtual reality imaging impacts decision-making in atrioventricular valve surgery Methods: This was a single centre retrospective  study involving 15 children and adolescents - median age 6 years (range 0.33 - 16) requiring surgica [....] » Read More

Giuseppe Nasso, Speaker at Cardiovascular Conferences
Oral Presentation (In-Person)
Giuseppe Nasso, Anthea Hospital GVM Care & Research, Italy

This presentation will discuss a retrospective analysis of the impact of administering the PCSK9 inhibitor evolocumab (140 mg/ml, subcutaneously twice a month) in addition to standard therapy (statins + ezetimibe) on LDL cholesterol levels and major adverse cardiovascular events [....] » Read More

Tutan Das, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Tutan Das, Vivekananda Hospital, India

Introduction: Hypertensive emergencies present diagnostic and therapeutic challenges, particularly in young patients. We present a compelling case of a 23-year-old female presenting with refractory hypertensive emergency, ultimately diagnosed with bilateral renal artery stenosis [....] » Read More

Alexandra Murtazaliyeva, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Alexandra Murtazaliyeva, JSC “Scientific Center of Obstetrics, Gynecology and Perinatology”, Kazakhstan

Introduction: Statistics show that about 10,000 open heart surgeries are performed in Kazakhstan, with more than 3,000 patients with acquired heart defects. Warfarin is the primary oral anticoagulant to prevent complications after surgery in Kazakhstan. Most studie [....] » Read More

Catherine Choi, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Catherine Choi, University of Oxford, United Kingdom

Introduction: The TMEM16A channel is a Ca2+-activated Cl- channel (CaCC) highly expressed in mammalian arterial smooth muscle. The channel connects Ca2+ release triggered by Gq protein-coupled receptor (GqPCR) activation with membrane depolarisation and smooth muscle contraction. [....] » Read More

Shreeya Mehta, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Shreeya Mehta, King’s College London, United Kingdom

Introduction: Hypertension is the primary preventable factor contributing to premature mortality and disability on a global scale – and a major risk factor for cardiovascular disease. ~ 50% of patients present with a ‘salt-sensitive’ hypertensive phenotype. Alon [....] » Read More

David W Yaffee, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
David W Yaffee, Hartford HealthCare, United States

Atrio-esophageal fistula is a rare but life-threatening complication of epicardial atrial ablation. Concomitant surgical repair of the heart and esophagus carries a high morbidity and mortality, especially when repair is attempted without cardiopulmonary bypass. We report the pre [....] » Read More

Shetuan Zhang, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Shetuan Zhang, Queen’s University, Canada

The human ether-a-go-go–related gene (hERG) encodes the potassium channel Kv11.1 (commonly known as hERG) that conducts the rapidly activating delayed rectifier potassium current (IKr). Normal function of hERG is critical for cardiac repolarization and its dysfunction cause [....] » Read More

Dascalescu Cristina Anca, Speaker at Cardiovascular conference
Oral Presentation (In-Person)
Dascalescu Cristina Anca, MED FAM Society, Romania

Motivation of the Work: Identification of barriers in enrolling patients, identification of risk factors, compliance and adherence to treatment and lifestyle changes proposed by specialists Compliance, the patient's behavioral response to the lifestyle change and the prescrib [....] » Read More

Marc Jason Ng, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Marc Jason Ng, Cardinal Santos Medical Center, Philippines

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are principally known as agents for the control of Type 2 diabetes mellitus (Type 2 DM). In recent years, they have gained more attention, especially for their role in cardiovascular protection in Type 2 diabetes patie [....] » Read More

Tutan Das, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Tutan Das, Vivekananda Hospital, India

Introduction: In the realm of percutaneous coronary intervention (PCI), the management of coronary artery calcium poses a significant challenge, particularly in cases of severe calcification and high-risk patients. Inadequate addressal leads to suboptimal outcomes in terms of ste [....] » Read More

Manidipa Majumdar, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Manidipa Majumdar, Gouri Devi Institute of Medical Sciences and Hospital, India

Introduction: STEMI mimickers have been described in literature for many decades, but each clinical interaction teaches us new ways to tackle these medical emergencies. This case underscores the need to individualize every case in an effort to avoid delaying life-saving treatment [....] » Read More

Lidia Lopez Garcia, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Lidia Lopez Garcia, San Carlos Clinical Hospital, Spain

The symptoms shown by frail patients with heart failure (HF) are sometimes different and the most common symptoms may be absent, delaying the diagnosis and finding patients with more severe HF. The use of lung ultrasound in these patients could help to objectify real congestion.& [....] » Read More

Sudheer Arava, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Sudheer Arava, AIIMS, India

Background and Aim Restrictive cardiomyopathy is one of the rarest types of cardiomyopathy with a prevalence of 1: 1500-2000 in USA. Clincioradiologicaly, it is characterized by normal ventricles, dilated atrial chambers with diastolic dysfunction. Many secondary etiological f [....] » Read More

Ansh Goswami, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Ansh Goswami, AIIMS, India

Background and Aim: Hypertrophic cardiomyopathy (HCM) is one of the common and primary genetic cardiomyopathy characterized by inappropriate hypertrophy of the interventricular septum and ventricle with variable clinical presentations, one of the commonest being sudden cardi [....] » Read More

Rona Barbie O Mendoza, Speaker at Cardiology Conference
Oral Presentation (In-Person)
Rona Barbie O Mendoza, Philippine Heart Center, Philippines

Introduction: ASD has a generally good prognosis and if left untreated can lead to PH. The present study was conducted to determine the predictors of treatment success among adult ASD with PH and develop a scoring system based on the identified factors. Methods: Adult patients wi [....] » Read More

Azam Jan, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Azam Jan, Rehman Medical Institute, Pakistan

Background: The aorta can be involved in different pathologies, including congenital, syndromic, and acquired disorders, which may need intervention in any form to prevent disasters. The purpose of this study was to review the types of aortic pathologies treated surgically and th [....] » Read More

Johannes Mueller, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Johannes Mueller, Berlin Heals, Germany

Device-based therapy for heart failure is essentially based on two systems available on the market and has only limited long-term success. The basis of these systems is the delivery of different electrical pulses to the myocardium. Based on the knowledge that physiologically cons [....] » Read More

Stephan Schueler, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Stephan Schueler, Newcastle upon Tyne Hospitals, United Kingdom

LVAD Therapy has become a safe and successful long-term therapy for patients with advanced heart failure. Off the shelf 24/7 availability allows to treat patients, when necessary, in time. Significant reduction of anticoagulation therapy in recent years has allowed to reduce blee [....] » Read More

Thomas Bernd Dschietzig, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany

Human relaxin-2 (hRlx-2) is a hormone of pregnancy that has engendered a great deal of interest as a therapy for various cardiovascular and inflammatory diseases, among them Acute Heart Failure and Systemic Scleroderma. Here, we propose and summarize data showing that Rlx-2 repre [....] » Read More

Mekhman N Mamedov, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation

Aim: The aim of the study is to analyze the risk of cardiovascular complications (CVC) in an unorganized population of men and women of working age in the Vladimir region. Material and methods: The cross-sectional population-based study included 1,350 men and women aged 3 [....] » Read More

Katherine Bianco, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Katherine Bianco, Stanford University, United States

Objective: To assess the association between maternal congenital heart disease (CHD) and adverse neonatal outcomes, focusing on birth weight, gestational age, Apgar scores, and neonatal intensive care unit (NICU) admissions. Study Design: A retrospective cohort study span [....] » Read More

Robert J Chilton, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Robert J Chilton, UT Health San Antonio, United States

Atherothrombotic disease, characterized by the formation of atherosclerotic plaques leading to arterial thrombosis, is a significant cause of morbidity and mortality worldwide. Despite considerable progress in therapeutic interventions, there remains an unmet need for novel treat [....] » Read More

Dae Wook Lee, Speaker at Heart Conferences
Oral Presentation (Virtual)
Dae Wook Lee, Novartis, Korea, Republic of

The potential applications of generative AI in the field of cardiology are remarkably broad. Recent research suggests that generative AI is expected to bring a wide range of innovations across the diagnosis and management of cardiovascular diseases. Particularly, the use of gener [....] » Read More

Maria Borrell, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Maria Borrell, Institut de Recerca Sant Pau - Centre CERCA, Spain

Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) and Low-Density Lipoprotein Receptor (LDLR) downr [....] » Read More

Okorafor Ugochi Chinenye, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Okorafor Ugochi Chinenye, Meridian Cardiac Center, Nigeria

Background: Serum uric acid (sUA) has been known to be associated with an increased risk of developing cardiovascular disease in different populations. However, whether this is also the case with Nigerian patients remains understudied. The study aimed to assess the associatio [....] » Read More

N Gokarneshan, Speaker at Heart Conferences
Oral Presentation (Virtual)
N Gokarneshan, SSM College of Engineering, India

In recent years, wearables are exploding in popularity as unobtrusive devices able to extend traditional healthcare delivery systems. Smart textiles are one of the main innovative types of wearables used for non invasive and continuous monitoring of cardiac activity. A prominent [....] » Read More

Najlae Adadi, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Najlae Adadi, Professor of Medical Genetics, Morocco

Background: Pompe disease is an autosomal recessive lysosomal storage disorder characterized by progressive myopathy with proximal muscle weakness, respiratory muscle dysfunction, and cardiomyopathy. Its prevalence ranges between 1/9000 and 1/40,000. It is caused by compound hete [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Rationale: Mesocardia is the heart in the middle compartment of the chest. The human heart is normally located within the thoracic cavity, medially between the lungs in the mediastinum. Marfan syndrome is an autosomal dominant disorder and multi-systemic genetic disorder that [....] » Read More

Agustin Joison, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Agustin Joison, Cordoba Catholic University, Argentina

Introduction: An understanding of the association between apolipoprotein B (Apo-B) and CRP (C-reactive protein) in the development of residual cardiovascular risk is very important when comparing it with atherogenic lipoproteins such as HDL-cholesterol, LDL-cholesterol. Apol [....] » Read More

Abdul Ghafoor Zarmalwal, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Abdul Ghafoor Zarmalwal, FMIC Hospital Kabul, Afghanistan

PFO is one of the most common congenital heart diseases  and fluoroscopic percutaneous closure devices based on non-degradable alloys have been widely used in clinical application and saved numerous patients but some developed countries using biodegradable closure devices un [....] » Read More

Cristina Milagre Quadros Borges, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Cristina Milagre Quadros Borges, Hcor-Hospital of Heart in Sao Paulo, Brazil

Smoking is considered a chronic disease caused by chemical dependence of nicotine. This is highly addicting, it in the brain system it influences our emotions, increases the feeling of pleasure/humor and reduces the anxiety. In a planet with about 8 billion people, around 1, [....] » Read More

Joao Rafael, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Joao Rafael, Connect Life Rehabilitation and Performance, Brazil

Chronic pain is defined as persistent pain for more than three months and can be classified as primary with no known etiology, or secondary pertinent to a pathological process and specific clinical diagnosis.In previous studies, we observed that it directly impacts cardiac rehabi [....] » Read More

Daniel L Cobo, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Daniel L Cobo, Faculty of Medicine of Sao Jose do Rio Preto, Brazil

Background: Univentricular heart (UH) is a rare congenital heart malformation, characterized by the absence of two well-developed ventricles and the presence of a single functional ventricle. In these cases, cardiac magnetic resonance imaging or catheterization can be used for pr [....] » Read More

Emerson Jose De Souza, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Emerson Jose De Souza, VanLab Innovations, Canada

Cardiac myocytes originating from different parts of the heart exhibit varying morphology and ultrastructure. However, the difference in their dynamic behavior is unclear. We examined the contraction of cardiac myocytes originating from the apex, ventricle, and atrium, and found [....] » Read More

Shakir Khan, Speaker at Heart Conferences
Oral Presentation (Virtual)
Shakir Khan, University Hospital Southampton, United Kingdom

This study aimed to examine the cardiometabolic index during early pregnancy in individuals with hypertension-complicating pregnancy, especially preeclampsia. Additionally, this study sought to determine the relationship between cardiometabolic index and the incidence of varying [....] » Read More

Chandramohan Deepak, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Chandramohan Deepak, University of Alabama at Birmingham, United States

The presentation will focus on the treatment and comprehensive management of Cardiorenal Syndrome (CRS) in the acute hospital setting, which is characterized by acute kidney injury resulting from acute decompensated heart failure. Various therapeutic strategies will be discussed& [....] » Read More

Zakir Khan, Speaker at Green Chemistry Conferences
Oral Presentation (Virtual)
Zakir Khan, University Hospital Southampton, United Kingdom

This study aimed to examine the cardiometabolic index during early pregnancy in individuals with hypertension-complicating pregnancy, especially preeclampsia. Additionally, this study sought to determine the relationship between cardiometabolic index and the incidence of varying [....] » Read More

Maheswara Satya, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Maheswara Satya, Guam Regional Medical City, United States

Background: Approximately 20.1 million adults in the United States are affected by coronary artery disease. Every year over 4 million coronary angiograms are being performed in Europe and the USA. Over 1700 cardiac catheterization laboratories were present across the United [....] » Read More

Wang Dongyan, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Wang Dongyan, Chongqing Red Cross Hospital, China

Objective: This study aims to provide an overview of recent research advancements in personalized care for tracheostomy patients and explore how personalized care can enhance the quality of life for patients with long-term tracheostomy. Methods and Materials: Through lit [....] » Read More

Zhongshu Zhou, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Zhongshu Zhou, The Thirteenth People's Hospital of Chongqing, China

Objective: To investigate the changes of serum lipoprotein-associated phospholipase A2 (Lp-PLA2), Soluble suppression of tumorigenicity 2 (sST2) and microcirculatory resistance reserve index (MRR) in patients with ST segment elevation myocardial infarction (STEMI) after percutane [....] » Read More

Hsuu Myat Moe Aung, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Hsuu Myat Moe Aung, Leeds Teaching Hospitals NHS Trust, United Kingdom

Background: Hypercholesterolaemia and poor blood glucose control are well known risk factors for developing myocardial infarction (MI). Preventative measures have been incorporated into several guidelines around the world. We aim to review our performance in adhering to the [....] » Read More

Okorafor Ugochi Chinenye, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Okorafor Ugochi Chinenye, Meridian Cardiac Center, Nigeria

Background: Cardiovascular diseases are the world’s number one cause of death. Various scoring systems and indicators, biochemical and otherwise, have arisen to help estimate the cardiovascular risk of populations, thus helping with screening and implementing measures to at [....] » Read More

Lucas Chronis, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Lucas Chronis, Queen’s University, Canada

Background: The New York Heart Association (NYHA) classification system is a subjective  assessment tool used by physicians to evaluate the functional status of patients. In the era of novel pharmacologic treatments for hypertrophic obstructive cardiomyopathy (HOCM), it is c [....] » Read More

Watsapp